Patients / Genentech Patient Foundation / Our Participating Medicines

Our Participating Medicines

The Genentech medicines supported by the Genentech Patient Foundation are:

Actemra^® (tocilizumab)
Activase^® (alteplase)
Alecensa^® (alectinib)
Avastin^® (bevacizumab)
Cathflo Activase^® (alteplase)
COLUMVI^™ (glofitamab-gxbm)
Cotellic^® (cobimetinib)
Enspryng^™ (satralizumab-mwge)
Erivedge^® (vismodegib)
Esbriet^® (pirfenidone)
Evrysdi^™ (risdiplam)
Gazyva^® (obinutuzumab)
Hemlibra^® (emicizumab-kxwh)
Herceptin^® (trastuzumab)
Herceptin Hylecta^™ (trastuzumab and hyaluronidase-oysk)
ITOVEBI™ (Inavolisib)
Kadcyla^® (ado-trastuzumab emtansine)

Lucentis^™ (ranibizumab injection)
LUNSUMIO^™ (mosunetuzumab-axgb)
OCREVUS^® (ocrelizumab)
OCREVUS ZUNOVO^™️ (ocrelizumab and hyaluronidase-ocsq)
Perjeta^® (pertuzumab)
Phesgo^™ (pertuzumab, trastuzumab, and hyaluronidase-zzxf)
PiaSky^™ (crovalimab-akkz)
Polivy^™ (polatuzumab vedotin-piiq)
Pulmozyme^® (dornase alfa)
Rituxan^® (rituximab)
Rituxan Hycela^™ (rituximab and hyaluronidase human)
Rozlytrek^™ (entrectinib)
Susvimo^™ (ranibizumab injection)
TECENTRIQ^® (atezolizumab)
TECENTRIQ HYBREZA^™ (atezolizumab and hyaluronidase-tqjs)
TNKase^® (tenecteplase)
Vabysmo^™ (faricimab)
Venclexta^® (venetoclax)
Xolair^® (omalizumab)
Zelboraf^® (vemurafenib)

Please Note: At this time, the Genentech Patient Foundation uses a separate process to support the following medicines:

CELLCEPT^{^®} (mycophenolate mofetil)
NUTROPIN AQ^{^®} (somatropin)

Learn more about support programs for these Genentech medicines here.

If you have been prescribed a participating medicine, you may qualify for support from the Genentech Patient Foundation. View the 'See If You Qualify' page to determine eligibility.

Support for Genentech medicines not listed above:

If you do not see your medicine listed, please contact our Patient Resource Center at 1 (877) GENENTECH (436-3683) for more information.